- Meeting abstract
- Open Access
Non viral gene therapy in arthritis by in vivo intramuscular IL-10 DNA electrotransfer
Arthritis Research & Therapy volume 4, Article number: 100 (2002)
Intramuscular electroporation of DNA is an attractive technique for nonviral gene transfer of therapeutic genes in inflammatory/autoimmune disease such as rheumatoid arthritis (RA). We have developed in vivo electroporation for efficient cytokine gene transfer in collagen induced arthritis.
We co-injected in the tibialis anterior of DBA1 mice a standard 30 ml dose of plasmid DNA encoding the anti-inflammatory cytokine viral interleukin-10 (vIL-10) under the control of a doxycycline-inducible promoter, and a plasmid expressing the tetracycline controlled transcriptional silencer (tTS) that binds promoter in absence of doxycycline. Electroporation was performed in vivo using 8 pulses of 200 v during 1 ms day 25 postimmunization of DBA1 mice with collagen type II.
Electroporation resulted in a dose-dependent increase in the vIL-10 expression in muscle and serum. The transgene was expressed only by muscle cells during 4 weeks. The doxycycline treatment showed significant inhibitory effects on DBA1 mice type II collagen induced arthritis (CIA) as paw swelling was reduced (1.79 ± 0.22 vs. 2.13 ± 0.84 mm on day 32 postimmunization) and onset of arthritis clinical delayed in the doxycycline-treated group compared with the control group without doxycycline (32.62 ± 4.50 days, versus 28.38 ± 3.62 days respectively).
Muscle-targeted vIL10-rtTA plasmid transfer by in vivo electroporation is a suitable approach for non viral gene therapy in arthritis.
About this article
Cite this article
Jorgensen, C., Apparailly, F., Perez, N. et al. Non viral gene therapy in arthritis by in vivo intramuscular IL-10 DNA electrotransfer. Arthritis Res Ther 4, 100 (2002). https://doi.org/10.1186/ar435
- Rheumatoid Arthritis
- Collagen Induce Arthritis
- Therapeutic Gene
- Significant Inhibitory Effect